{
    "title": "Cancer not treated by Vitamin D when ignore dose size, type, and length of trial \u2013 meta-analysis",
    "slug": "cancer-not-treated-by-vitamin-d-when-ignore-dose-size-type-and-length-of-trial-meta-analysis",
    "aliases": [
        "/Cancer+not+treated+by+Vitamin+D+when+ignore+dose+size+type+and+length+of+trial+\u2013+meta-analysis+April+2018",
        "/9510"
    ],
    "tiki_page_id": 9510,
    "date": "2018-04-09",
    "categories": [
        "Cancer",
        "Meta-analysis of Vitamin D"
    ],
    "tags": [
        "Cancer",
        "Meta-analysis of Vitamin D",
        "cancer",
        "dosage",
        "vitamin d"
    ]
}


#### Cancer and vitamin D supplementation: a systematic review and meta-analysis

The American Journal of Clinical Nutrition, Volume 107, Issue 4, 1 April 2018, Pages 652–663, https://doi.org/10.1093/ajcn/nqx047

Beatriz Goulão  Fiona Stewart  John A Ford  Graeme MacLennan Alison Avenell

<div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">

 **They ignored** 

* Dose Size: They gave 42% of the weight to a single trial with only  **800 IU**  of vitamin D

   * Probably because that single trial had the highest Cancer incidence

* Types - included Vitamin D2, active vitamin D, and Vitamin D analogs

* Vitamin D level achieved (which is a function of both dose size and trial duration)